Ledikast

Ledipasvir & Sofosbuvir Tablets

Send Enquiry

Medicine*

Your Name*

Your Email*

Your Phone*

Your Country*

Message

Categories: Hepatitis-C, Hepatology

Description
Download Product PDF Attachment

Description

COMPOSITION: Each tablet contains Sofosbuvir 400 + Ledipasvir 90 mg

INDICATION: LEDIKAST is a fixed dose combination of hepatitis C virus nucleotide analog NSSB polymerase
inhibitor and NSSA inhibitor indicated for the treatment of:

Indicated for the treatment of chronic HCV genotype 1 in adults

PACKING: 28 Tablets / Bottle

Download Product PDF Attachment

Disclaimer: This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence-based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. The website does not sell/purchase any medicine.

This website uses cookies to help us give you the best experience when you visit. By using this website you consent to our Terms of Use. For more information please click here. Accept

Ledikast

Thank you for your enquiry. We will get back to you shortly!

Description

Related products